Reversal of graft-versus-host disease with infusion of autologous bone marrow

Cell Transplant. 1994 Mar-Apr;3(2):187-92. doi: 10.1177/096368979400300207.

Abstract

Graft-versus-host disease (GVHD) remains a major complication of bone marrow transplantation. This report describes reversal of GVHD by infusion of stored recipient bone marrow following combined liver-bone marrow allotransplantation. Graft-versus-host disease developed at the end of the first postoperative week. The skin involvement progressively spread to approximately 80% of the body surface and was not affected by modification of the immunosuppressive treatment. On the 42nd and 43rd postoperative day 1.23 x 10(8) and 1.6 x 10(8) autologous bone marrow cells per kg of recipient body weight were infused. The skin rush began to dramatically improve and resolved within 2 wk from the autologous marrow infusion. Autologous bone marrow storage previous to allogeneic bone marrow transplantation for tolerance induction could constitute a safety net in case of occurrence of GVHD.

Publication types

  • Case Reports

MeSH terms

  • Biopsy
  • Bone Marrow Transplantation / immunology*
  • Cytotoxicity, Immunologic
  • Graft vs Host Disease / immunology*
  • Graft vs Host Disease / therapy
  • Humans
  • Leiomyosarcoma / surgery
  • Liver Neoplasms / secondary*
  • Liver Neoplasms / surgery
  • Liver Transplantation / immunology*
  • Liver Transplantation / pathology
  • Male
  • Middle Aged
  • Skin / immunology
  • Skin / pathology
  • Stomach Neoplasms / surgery
  • Time Factors
  • Transplantation, Autologous / immunology